Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To develop and validate the noninvasive measurement of MBF and MFR by using dynamic imaging with a CZT camera, and evaluate the diagnostic and prognostic implications in various heart disease.
Absolute myocardial blood flow (MBF) and myocardial flow reserve (MFR) provide incremental diagnostic and prognostic information over relative perfusion alone. Recent development of dedicated cardiac SPECT cameras with better sensitivity and temporal resolution make dynamic SPECT imaging more practical. The potential roles of myocardial perfusion in subjects with cardiovascular risks and heart failure warrant further investigations.
The present project aims to develop and validate the noninvasive measurement of MBF and MFR by using dynamic imaging with a CZT camera, and evaluate the diagnostic and prognostic implications.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| thallium-201 | Radiation | Thallium (Tl-201) myocardial single photon emission tomography, dynamic imaging |
| Measure | Description | Time Frame |
|---|---|---|
| Coronary artery disease (CAD) diagnosis | CAD defined as more than 50% stenosis in any vessel by coronary angiography or computed tomography. | 12 months after the index MPI |
| Measure | Description | Time Frame |
|---|---|---|
| MACE (major adverse cardiac events) | revascularization, acute myocardial infarction, hospitalization for heart failure, cardiac death, non-cardiac death | 5 years after the index MPI |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Significant systemic disease (except heart disease) such as cirrhosis, end-stage renal disease or active malignancy, estimated life expectancy of less than three months, persons; pregnant or lactating women have the possibility of pregnancy.
Not provided
Not provided
Subjects with clinically suspected coronary artery disease, heart failure, or intermediate and high cardiovascular risks
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Yen-Wen Wu, MD, PhD | Far Eastern Memorial Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Far Eastern Memorial Hospital | New Taipei City | 220 | Taiwan |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| ID | Term |
|---|---|
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C000615114 | Thallium-201 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided